Effects of selective and combined serotonin and dopamine depletion on the loudness dependence of the auditory evoked potential (LDAEP) in humans

Human Psychopharmacology

Volumn 23, Issue 4, 2008, Pages 301-312

  O'Neill, Barry V ^a,b,e   Guille, Valérie ^a   Croft, Rodney J ^a,b   Leung, Sumie ^a   Scholes, Kirsty E ^d   Phan, K Luan ^c   Nathan, Pradeep J ^b,e  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Amino acid depletion; Catecholamines; Dopamine; Evoked potentials; Loudness depeadence auditory evoked potentials; Serotonin

Indexed keywords

DOPAMINE; ISOLEUCINE; LEUCINE; MONOAMINE; PHENYLALANINE; PLACEBO; SEROTONIN; TRYPTOPHAN; TYROSINE; VALINE;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID COMPOSITION; ANALYSIS OF VARIANCE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; EVOKED AUDITORY RESPONSE; HUMAN; HUMAN EXPERIMENT; INFORMED CONSENT; LOUDNESS; MALE; MOOD CHANGE; NEUROTRANSMISSION; NORMAL HUMAN; ORANGE JUICE; PRIORITY JOURNAL; PROTEIN RESTRICTION;

ACOUSTIC STIMULATION; ADULT; CROSS-OVER STUDIES; DOPAMINE; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; EVOKED POTENTIALS, AUDITORY; HUMANS; LOUDNESS PERCEPTION; MALE; PHENYLALANINE; SEROTONIN; TRYPTOPHAN; TYROSINE;

EID: 47249091013     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.926     Document Type: Article

References (62)

1. Baribeau JC, Laurent JP. 1987. The effect of selective attention on augmenting/intensity function of the early negative waves of AEP's. Electroencephalog and Clin Neurophysiol S40: 68-75.
2. Bel N, Artigas F. 1996. Reduction of serotonergic function in rat brain by tryptophan depletion: effects in control and fluvoxamine-treated rats. J Neurochem 67: 669-676.
3. Bond A, Lader M. 1974. The use of analogue scales in rating subjective feelings. Br J Med Psychol 47: 211-218.
4. Bruneau N, Barthelemy C, Jouve J, Lelord G. 1986. Frontal auditory-evoked potential augmenting-reducing and urinary homovanillic acid. Neuropsychobiology 16: 78-84.
5. Buchner A, Erdfelder E, Faul F. 1997. How to Use G*Power [WWW document]. URL: http://www.psycho.uni-duesseldorf.de/aap/projects/gpower/ how_to_use_gpower.html
6. Buchsbaum MS, Pfefferbaum A. 1971. Individual Differences in Stimulus intensity response. Psychophysiology 8: 600-612.
7. Carpenter LL, Anderson GM, Pelton GH, et al. 1998. Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology 19: 26-35.
8. Cohen SA. 2000. Methods in molecular biology. In Amino Acid Analysis Using Precolumn Derivatisation With 6-aminoquino lyl-N-Hydroxysuccinimidyl Carbamate, Cooper C, Packer N, Williams K (eds). Humana Press: New Jersey; 39-47.
9. Croft RJ, Barry RJ. 2000. EOG correction of blinks with saccade coeffecients: a test and revision of the aligned-artefact average solution. Clin Neurophysiol 111: 444-451.
10. Croft RJ, Klugman A, Baldeweg T, Gruzelier JH. 2001. Electrophysiological evidence of serotonergic impairment in long-term MDMA ("Ecstasy") users. Am J Psychiatry 158: 1687-1692.
11. Debener S, Strobel A, Kurschner K, et al. 2002. Is auditory evoked potential augmenting/reducing affected by acute tryptophan depletion? Biol Psychol 59: 121-133.
12. Dierks T, Barta S, Demisch L, et al. 1999. Intensity dependence of auditory evoked potentials (AEPs) as biological marker for cerebral serotonin levels: effects of tryptophan depletion in healthy subjects. Psychopharmacology 146: 101-107.
13. Fernstrom J. 1979. Diet-induced changes in plasma amino acid pattern: effects on the brain uptake of large neutral amino acids and on brain serotonin synthesis. J Neural transm Suppl 15: 55-67.
14. Gallinat J, Bottlender R, Juckel G, Munke-Puchner A, Stotz G, Kuss HJ. 2000. The loudness dependence of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression Psychopharmacology. 148: 404-411.
15. Gallinat J, Senkowski D, Wernicke C, et al. 2003. Allelic variants of the functional promoter polymorphism of the human serotonin transporter gene is associated with auditory cortical stimulus processing. Neuropsychopharmacology 28: 530-532.
16. Guille V, Croft RJ, O'Neill BV, Ilic S, Phan KL, Nathan PJ. 2007. An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline. Hum Psychopharmacol. In press.
17. Harmer CJ, McTavish SF, Clark L, Goodwin GM, Cowen PJ. 2001. Tyrosine depletion attenuates dopamine function in healthy volunteers. Psychopharmacology 154: 105-111.
18. Harrison BJ, Olver JS, Norman TR, Burrows GD, Wesnes KA, Nathan PJ. 2004. Selective effects of acute serotonin and catecholamine depletion on memory in healthy women. J Psychopharmacol 18: 32-40.
19. Hegerl U, Bottlender R, Gallinat J, Kuss HJ, Ackenheil M, Moller HJ. 1998. The serotonin syndrome scale: first results on validity. Eur Arch Psychiatry Clin Neurosci 248: 96-103.
20. Hegerl U, Gallinat J, Juckel G. 2001. Event-related potentials Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists? J Affect Disord 62: 93-100.
21. Hegerl U, Juckel G. 1993. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 33: 173-187.
22. Hensch T, Wargelius HL, Herold U, Lesch KP, Oreland L, Brocke B. 2006. Further evidence for an association of 5-HTTLPR with intensity dependence of auditory-evoked potentials. Neuropsychopharmacology 31: 2047-2054.
23. Hood SD, Bell CJ, Nutt DJ. 2005. Acute tryptophan depletion. Part I: rationale and methodology. Aust N Z J Psychiatry 39: 558-564.
24. Juckel G, Gallinat J, Riedel M, et al. 2003. Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res 64: 115-124.
25. Juckel G, Hegerl U, Molnar M, Csepe V, Karmos G. 1999. Auditory, evoked potentials reflect serotonergic neuronal activity - a study in behaving cats administered drugs acting on 5-HT1A auto-receptors acting in the dorsal raphe nucleus. Neuropsychopharmacology 21: 710-716.
26. Juckel G, Molnar M, Hegerl U, Csepe V, Karmos G. 1997. Auditory evoked potentials as indicator of brain serotonergic activity - first evidence in behaving cats. Biol Psychiatry 41: 1181-1195.
27. Kähkönen S, Jaaskelainen IP, Pennanen S, Liesivuori J, Ahveninen J. 2002. Acute tryptophan depletion decreases intensity dependence of auditory evoked magnetic N1/P2 dipole source activity. Psychopharmacology 164: 221-227.
28. Lee TW, Yu YW, Chen TJ, Tsai SJ. 2005. Loudness dependence of the auditory evoked potential and response to antidepressants in Chinese patients with major depression. J Psychiatry Neurosci 30: 202-205.
29. Lesch KP, Bengel D, Heils A, et al. 1996. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274: 1527-1531.
30. Leyton M, Young SN, Pihl RO, et al. 1999. A comparison of the effects of acute tryptophan depletion and acute phenylalanine/tyrosine depletion in healthy women. Adv Exp Med Biol 467: 67-71.
31. Luciana M, Collins PF, Depue RA. 1998. Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. Cereb Cortex 8: 218-226.
32. Mann C, Croft RJ, Scholes KE, et al. 2007. Differential effects of acute serotonin and dopamine depletion on prepulse inhibition and P50 suppression measures of sensory gating. Neuropsychopharmacology advance online publication, 26 September 2007. DOI:10.1038/sj.npp.1301556
33. Massey AE, Marsh VR, McAllister-Williams RH. 2004. Lack of effect of tryptophan depletion on the loudness dependency of auditory event related potentials in healthy volunteers. Biol Psychol 65: 137-145.
34. Matrenza C, Hughes JM, Kemp AH, Wesnes KA, Harrison BJ, Nathan PJ. 2004. Simultaneous depletion of serotonin and catecholamines impairs sustained attention in healthy female subjects without affecting learning and memory. J Psychopharmacol 18: 21-31.
35. McTavish SF, Callado L, Cowen PJ, Sharp T. 1999a. Comparison of the effects of alpha-methyl-p-tyrosine and a tyrosine-free amino acid load on extracellular noradrenaline in the rat hippocampus in vivo. J Psychopharmacol 13: 379-384.
36. McTavish SF, Cowen PJ, Sharp T. 1999b. Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release. Psychopharmacology 141: 182-188.
37. Moja EA, Cippola P, Castoldi D, Tofanetti O. 1989. Dose-response decrease in plasma tryptophan and in brain tryptophan and serotonin after tryptophan-free amino acid mixtures in rats. Life Sci 44: 971-976.
38. Moja EA, Stoff DM, Gessa GL, Castoldi D, Assereto R, Tofanetti O. 1988. Decrease in plasma tryptophan after tryptophan-free amino acid mixtures in man. Life Sci 42: 1551-1556.
39. Mongeau R, Blier P, de Montigny C. 1997. The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Brain Res Rev 23: 145-195.
40. Montgomery AJ, McTavish SF, Cowen PJ, Grasby PM. 2003. Reduction of brain dopamine concentration with dietary tyrosine plus phenylalanine depletion: an [11C]raclopride PET study. Am J Psychiatry 160: 1887-1889.
41. Moore P, Landolt HP, Seifritz E, et al. 2000. Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology 23: 601-622.
42. Nathan PJ, Hughes JM, McInerney B, Harrison BJ. 2004. Simultaneous depletion of tryptophan, tyrosine and phenylalanine as an experimental method to probe brain monoamine function in human. Int J Neuropsychopharmacol 7: 171-176.
43. Nathan PJ, Segrave R, Phan KL, O'Neill B, Croft RJ. 2006. Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function. Hum Psychopharmacol 21: 47-52.
44. Nishizawa S, Benkelfat C, Young SN, et al. 1997. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A 94: 5308-5313.
45. Norra C, Becker S, Bröcheler A, Kawohl W, Kunert HJ, Buchner H. 2008. Loudness dependence of evoked dipole source activity during acute serotonin challenge in females. Hum Psychopharmacol 23: 31-42.
46. O'Neill BV, Croft RJ, Leung S, et al. 2006. Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans. Psychopharmacology 188: 92-99.
47. O'Neill BV, Croft RJ, Leung S, Oliver C, Luan Phan K, Nathan PJ. 2007. High dose glycine inhibits the loudness dependence of the auditory evoked potential (LDAEP) in healthy humans. Psychopharmacology 195(1): 85-93.
48. Palmour RM, Ervin FR, Baker GB, Young SN. 1998. An amino acid mixture deficient in phenylalanine and tyrosine reduces cerebrospinal fluid catecholamine metabolites and alcohol consumption in vervet monkeys. Psychopharmacology 136: 1-7.
49. Pogarell O, Tatsch K, Juckel G, et al. 2004. Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder. Neuropsychopharmacology 29: 1910-1917.
50. Reilly JG, McTavish SF, Young AH. 1997. Rapid depletion of plasma tryptophan: a review of studies and experimental methodology. J Psychopharmacol 11: 381-392.
51. Sambeth A, Blokland A, Harmer CJ, et al. 2007. Sex differences in the effect of acute tryptophan depletion on declarative episodic memory: a pooled analysis of nine studies. Neurosci Biobehav Rev 31(4): 516-529.
52. Senkowski D, Linden M, Zubragel D, Bar T, Gallinat J. 2003. Evidence for disturbed cortical signal processing and altered serotonergic neurotransmission in generalized anxiety disorder. Biol Psychiatry 53: 304-314.
53. Simpson GV, Knight RT. 1993. Multiple brain systems generating the rat auditory evoked potential. I. Characterization of the auditory cortex response. Brain Res 602: 240-250.
54. Spoont MR. 1992. Modulatory role of serotonin in neural information processing: implications for human psychopathology. Psychol Bull 112: 330-350.
55. Strobel A, Debener S, Schmidt D, Hunnerkopf R, Lesch KP, Brocke B. 2003. Allelic variation in serotonin transporter function associated with the intensity dependence of the auditory evoked potential. Am J Med Genet B Neuropsychiatr Genet 118B: 41-47.
56. Tuchtenhagen F, Daumann J, Norra C, et al. 2000. High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent ecstasy (MDMA) users. Neuropsychopharmacology 22: 608-617.
57. Uhl I, Gorynia I, Gallinat J, et al. 2006. Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects? Hum Psychopharmacol 21: 463-471.
58. Van der Does AJ. 2001. The effects of tryptophan depletion on mood and psychiatric symptoms. J Affect Disord 64: 107-119.
59. Von Knorring L, Perris C. 1981. Biochemistry of the augmenting/reducing response in visual evoked potentials. Neuropsychobiology 7: 1-8.
60. Williams WA, Shoaf SE, Hommer D, Rawlings R, Linnoila M. 1999. Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers. J Neurochem 72: 1641-1647.
61. Young SN, Smith SE, Pihl RO, Ervin FR. 1985. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 87: 173-177.
62. Zemon V, Kaplan E, Ratliff F. 1986. The role of GABA-mediated intracortical inhibition in the generation of visual evoked potentials. In Evoked Potentials, Cracco RQ, Bodis-Wollner I (eds). New York Academy of Science: New York; 287-295.